Getting research findings into practice: Decision analysis and the implementation of research findings

British Medical Journal

Volumn 317, Issue 7155, 1998, Pages 405-409

  Lilford, R J ^a,b   Pauker, S G ^c   Braunholtz, D A ^a   Chard, Jiri ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b Dept of Health Services Research ^*

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR;

EVIDENCE BASED MEDICINE; HEART INFARCTION; HUMAN; MEDICAL DECISION MAKING; MEDICAL PRACTICE; MEDICAL RESEARCH; PRIORITY JOURNAL; PROBABILITY; SHORT SURVEY; STROKE; DECISION SUPPORT SYSTEM; PROFESSIONAL PRACTICE; RESEARCH; REVIEW; SENSITIVITY AND SPECIFICITY;

DECISION SUPPORT TECHNIQUES; PROBABILITY; PROFESSIONAL PRACTICE; RESEARCH; SENSITIVITY AND SPECIFICITY;

EID: 0032497026     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.317.7155.405     Document Type: Short Survey

References (22)

1. Glaszion PP, Irwig LM. An evidence based approach to individualising treatment. BMJ 1995;311:1356-9.
2. Keeney RL, Raiffa H. Decisions with multiple objectives. London: Wiley, 1976.
3. Weinstein M, Fineberg HV. Clinical decision analysis. London: Saunders, 1980.
4. French S. Readings in decision analysis. London: Chapman and Hall, 1989.
5. Sox HC, Blatt MA, Higgins MC, Marton KI. Medical decision making. Boston: Butterworth Heinemann, 1988.
6. Second International Study of Infarct Survival (ISIS 2) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected myocardial intarction: ISIS 2. Lancet 1988;ii:349-60.
7. Kellett J, Clarke J. Comparison of accelerated tissue plasminogen activator with streptokinase for treatment of suspected myocardial infarction. Med Decis Making 1995;15:297-310.
8. Tsevat J, Goldman L, Lamas GA. Functional status versus utilities in sunvivors of myocardial infarction. Med Care 1991;29:1153-9.
9. Lilford RJ, Braunholtz D. The statistical basis of public policy: a paradigm shift is overdue. BMJ 1996;313:603-7.
10. Donner A. A bayesian approach to the interpretation of sub-group results in clinical trials. J Chronic Dis 1982;34:429-35.
11. Oxman AD, Guyatt GH. A consumer's guide to sub-group analyses. Ann Intern Med 1992;116:78-84.
12. Swales J. Science in a health service. Lancet 1997;349:1319-21.
13. Lilford RJ. Trade-off between gestational age and miscarriage risk of prenatal testing: does it vary according to genetic risk? Lancet 1990;336:1303-5.
14. Johnson N, Lilford R, Jones SE, McKenzie L, Billingsley P, Songane FF. Decision analysis to calculate optimum treatment for microinvasive cervical cancer. Br J Cancer 1992;65:717-22.
15. Lilford RJ, Jackson J. Equipoise and the ethics of randomisation. J R Soc Med 1995;88:552-9.
16. Pauker SP, Pauker SG. Prenatal diagnosis: a directive approach to genetic counselling using decision analysis. Yale J Biol Med 1977;50:275-89.
17. Sculpher M, Michaels J, McKenna M, Minor J. A cost-utility analysis of laser-assisted angioplasty for peripheral arterial occlusions. Int J Technol Assess Health Care 1996;12:101-25.
18. Johnson N, Lilford RJ, Mayers D, Johnson GG, Johnson JM. Do healthy asymptomatic post menopausal women want routine evclical hormone replacement? A utility analysis. J Obstet Gynecol 1994;14:35-9.
19. Col NF, Eckman MH, Kara RH, Pauker SG, Goldberg RJ, Ross EM, et al. Patient-specific decisions about hormone replacement therapy in postmenopausal women. JAMA 1991;277:1140-7.
20. Dawes R, Faust D, Meehl PE. Clinical versus actuarial judgement. Science 1989;243:1668-74.
21. Dowie J. "Evidence-based," "cost-effective" and "preference-driven" medicine: decision analysis based medical decision making is the pre-requisite. J Health Serv Res Policy 1996;1:104-13.
22. Dowie J. The research-practice gap and the role of decision analysis in closing it. Health Care Analysis 1996;4:5-18.